1-229595028-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014409.4(TAF5L):āc.1039A>Gā(p.Ser347Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000052 in 1,614,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014409.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250444Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135374
GnomAD4 exome AF: 0.0000506 AC: 74AN: 1461790Hom.: 0 Cov.: 33 AF XY: 0.0000605 AC XY: 44AN XY: 727196
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152342Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2021 | The c.1039A>G (p.S347G) alteration is located in exon 5 (coding exon 4) of the TAF5L gene. This alteration results from a A to G substitution at nucleotide position 1039, causing the serine (S) at amino acid position 347 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at